Advertisement

International Urology and Nephrology

, Volume 50, Issue 11, pp 1981–1988 | Cite as

Neuroprotective effects of melatonin on erectile dysfunction in streptozotocin-induced diabetic rats

  • Jiang-lei Zhang
  • Yu Hui
  • Feng ZhouEmail author
  • Jian-Quan HouEmail author
Urology - Original Paper
  • 132 Downloads

Abstract

Purpose

To explore the neuroprotective effects and its possible mechanisms of melatonin (MT) on erectile dysfunction in streptozotocin-induced diabetic rats.

Methods

Twenty-eight Sprague–Dawley rats received intraperitoneal injection of streptozotocin and 8 weeks later, the determined diabetic rats randomly got intraperitoneal injection of phosphate buffer solution (PBS) or MT. Another 12 normal rats received PBS treatment. Four weeks later, intracavernous pressure, mean arterial pressure, pathological changes in penis, and major pelvic ganglion (MPG) were measured. Malondialdehyde, superoxide dismutase, p38 and p-p38 levels in penis were detected.

Results

Diabetic rats showed significant decreases of erectile function accompanied with serious neuropathy in dorsal penile nerve (DPN) and MPG, meanwhile collagen deposition, oxidative stress, and p-p38 levels in penis were elevated. Melatonin treatment partially but significantly improved the erectile function, ameliorated neuropathy in DPN and MPG, and decreased collagen deposition, oxidative stress, and p-p38 levels in diabetic rats.

Conclusions

Melatonin treatment helps improve erectile function and ameliorate neuropathy and fibrosis in diabetic rats. These may be associated with reductions in oxidative stress, p38MAPK signaling pathway, and neuropathy.

Keywords

Erectile dysfunction Diabetes mellitus Melatonin Neuroprotective Anti-oxidation p-P38 

Notes

Funding

This study was funded by the National Natural Science Foundation of China (No. 81641165), Jiangsu Provincial Medical Youth Talent Foundation (QNRC2016720), China Postdoctoral Science Foundation (2015M580466), and Postdoctoral Science Foundation of Jiangsu Province (2016T90497).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical approval

All applicable international, national, and/or institutional guidelines for the care and use of animals were followed; all procedures performed in studies involving animals were in accordance with the ethical standards of the Committee for Animal Care and Use of Soochow University.

References

  1. 1.
    Thorve VS, Kshirsagar AD, Vyawahare NS, Joshi VS, Ingale KG, Mohite RJ (2011) Diabetes-induced erectile dysfunction: epidemiology, pathophysiology and management. J Diabetes Complic 25(2):129–136.  https://doi.org/10.1016/j.jdiacomp.2010.03.003 CrossRefGoogle Scholar
  2. 2.
    Walsh TJ, Hotaling JM, Smith A, Saigal C, Wessells H (2014) Men with diabetes may require more aggressive treatment for erectile dysfunction. Int J Impot Res 26(3):112–115.  https://doi.org/10.1038/ijir.2013.46 CrossRefPubMedGoogle Scholar
  3. 3.
    Matsui H, Sopko NA, Hannan JL, Bivalacqua TJ (2015) Mini review: pathophysiology of erectile dysfunction. Curr Drug Targets 16:411–419CrossRefGoogle Scholar
  4. 4.
    Hosseini A, Abdollahi M (2013) Diabetic neuropathy and oxidative stress: therapeutic perspectives. Oxid Med Cell Longev 2013:168039.  https://doi.org/10.1155/2013/168039 CrossRefPubMedPubMedCentralGoogle Scholar
  5. 5.
    He SH, Wei AY, Ye TY, Yang Y, Luo XG, Liu Y, Zhang T (2011) Calcitonin gene-related peptide induces phenotypic transformation of corpus cavernosum smooth muscle cells in diabetic rats with erectile dysfunction. Natl J Androl 17(10):913–917Google Scholar
  6. 6.
    Gur S, Kadowitz PJ, Hellstrom WJ (2009) A critical appraisal of erectile function in animal models of diabetes mellitus. Int J Androl 32(2):93–114.  https://doi.org/10.1111/j.1365-2605.2008.00928.x CrossRefPubMedGoogle Scholar
  7. 7.
    Bai GY, Zhou F, Hui Y, Xu YD, Lei HE, Pu JX, Xin ZC (2014) Effects of Icariside II on corpus cavernosum and major pelvic ganglion neuropathy in streptozotocin-induced diabetic rats. Int J Mol Sci 15(12):23294–23306.  https://doi.org/10.3390/ijms151223294 CrossRefPubMedPubMedCentralGoogle Scholar
  8. 8.
    Jenwitheesuk A, Nopparat C, Mukda S, Wongchitrat P, Govitrapong P (2014) Melatonin regulates aging and neurodegeneration through energy metabolism, epigenetics, autophagy and circadian rhythm pathways. Int J Mol Sci 15(9):16848–16884.  https://doi.org/10.3390/ijms150916848 CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Wongprayoon P, Govitrapong P (2017) Melatonin as a mitochondrial protector in neurodegenerative diseases. Cell Mol Life Sci 74(21):3999–4014.  https://doi.org/10.1007/s00018-017-2614-x CrossRefPubMedGoogle Scholar
  10. 10.
    Cellek S, Foxwell NA, Moncada S (2003) Two phases of nitrergic neuropathy in streptozotocin-induced diabetic rats. Diabetes 52(9):2353–2362CrossRefGoogle Scholar
  11. 11.
    Qiu XF, Li XX, Chen Y, Lin HC, Yu W, Wang R, Dai YT (2012) Mobilisation of endothelial progenitor cells: one of the possible mechanisms involved in the chronic administration of melatonin preventing erectile dysfunction in diabetic rats. Asian J Androl 14(3):481–486.  https://doi.org/10.1038/aja.2011.161 CrossRefPubMedPubMedCentralGoogle Scholar
  12. 12.
    Zhou F, Xin H, Liu T, Li GY, Gao ZZ, Liu J, Li WR, Cui WS, Bai GY, Park NC, Xin ZC (2012) Effects of icariside II on improving erectile function in rats with streptozotocin-induced diabetes. J Androl 33(5):832–844.  https://doi.org/10.2164/jandrol.111.015172 CrossRefPubMedGoogle Scholar
  13. 13.
    Xu Y, Guan R, Lei H, Li H, Wang L, Gao Z, Song W, Xin Z (2014) Therapeutic potential of adipose-derived stem cells-based micro-tissues in a rat model of postprostatectomy erectile dysfunction. J Sex Med 11(10):2439–2448.  https://doi.org/10.1111/jsm.12636 CrossRefPubMedGoogle Scholar
  14. 14.
    Moore CR, Wang R (2006) Pathophysiology and treatment of diabetic erectile dysfunction. Asian J Androl 8(6):675–684.  https://doi.org/10.1111/j.1745-7262.2006.00223.x CrossRefPubMedGoogle Scholar
  15. 15.
    Zheng H, Bidasee KR, Mayhan WG, Patel KP (2007) Lack of central nitric oxide triggers erectile dysfunction in diabetes. Am J Physiol Regulat Integr Comp Physiol 292(3):R1158–R1164.  https://doi.org/10.1152/ajpregu.00429.2006 CrossRefGoogle Scholar
  16. 16.
    Kamenov ZA (2015) A comprehensive review of erectile dysfunction in men with diabetes. Exp Clin Endocrinol Diabetes 123(3):141–158.  https://doi.org/10.1055/s-0034-1394383 CrossRefPubMedGoogle Scholar
  17. 17.
    Sawada N, Nomiya M, Zarifpour M, Mitsui T, Takeda M, Andersson KE (2016) Melatonin improves erectile function in rats with chronic lower body ischemia. J Sex Med 13(2):179–186.  https://doi.org/10.1016/j.jsxm.2015.12.018 CrossRefPubMedGoogle Scholar
  18. 18.
    Kahya MC, Naziroglu M, Ovey IS (2017) Modulation of diabetes-induced oxidative stress, apoptosis, and Ca(2+) entry through TRPM2 and TRPV1 channels in dorsal root ganglion and hippocampus of diabetic rats by melatonin and selenium. Mol Neurobiol 54(3):2345–2360.  https://doi.org/10.1007/s12035-016-9727-3 CrossRefPubMedGoogle Scholar
  19. 19.
    Wang L, Xu Y, Li H, Lei H, Guan R, Gao Z, Xin Z (2015) Antioxidant icariside II combined with insulin restores erectile function in streptozotocin-induced type 1 diabetic rats. J Cell Mol Med 19(5):960–969.  https://doi.org/10.1111/jcmm.12480 CrossRefPubMedPubMedCentralGoogle Scholar
  20. 20.
    Tavukcu HH, Sener TE, Tinay I, Akbal C, Ersahin M, Cevik O, Cadirci S, Reiter RJ, Sener G (2014) Melatonin and tadalafil treatment improves erectile dysfunction after spinal cord injury in rats. Clin Exp Pharmacol Physiol 41(4):309–316.  https://doi.org/10.1111/1440-1681.12216 CrossRefPubMedGoogle Scholar
  21. 21.
    Kimball SR, Abbas A, Jefferson LS (2008) Melatonin represses oxidative stress-induced activation of the MAP kinase and mTOR signaling pathways in H4IIE hepatoma cells through inhibition of Ras. J Pineal Res 44(4):379–386.  https://doi.org/10.1111/j.1600-079X.2007.00539.x CrossRefPubMedPubMedCentralGoogle Scholar
  22. 22.
    Purves T, Middlemas A, Agthong S, Jude EB, Boulton AJ, Fernyhough P, Tomlinson DR (2001) A role for mitogen-activated protein kinases in the etiology of diabetic neuropathy. FASEB J 15(13):2508–2514.  https://doi.org/10.1096/fj.01-0253hyp CrossRefPubMedGoogle Scholar
  23. 23.
    Zhou J, Du X, Long M, Zhang Z, Zhou S, Zhou J, Qian G (2016) Neuroprotective effect of berberine is mediated by MAPK signaling pathway in experimental diabetic neuropathy in rats. Eur J Pharmacol 774:87–94.  https://doi.org/10.1016/j.ejphar.2016.02.007 CrossRefPubMedGoogle Scholar
  24. 24.
    Nangle MR, Cotter MA, Cameron NE (2006) Correction of nitrergic neurovascular dysfunction in diabetic mouse corpus cavernosum by p38 mitogen-activated protein kinase inhibition. Int J Impot Res 18(3):258–263.  https://doi.org/10.1038/sj.ijir.3901414 CrossRefPubMedGoogle Scholar
  25. 25.
    Ma J, Shi M, Zhang X, Liu X, Chen J, Zhang R, Wang X, Zhang H (2018) GLP1R agonists ameliorate peripheral nerve dysfunction and inflammation via p38 MAPK/NFkappaB signaling pathways in streptozotocininduced diabetic rats. Int J Mol Med 41(5):2977–2985.  https://doi.org/10.3892/ijmm.2018.3509 CrossRefPubMedGoogle Scholar
  26. 26.
    Liu T, Peng Y, Jia C, Fang X, Li J, Zhong W (2015) Hepatocyte growth factor-modified adipose tissue-derived stem cells improve erectile function in streptozotocin-induced diabetic rats. Growth Factors 33(4):282–289.  https://doi.org/10.3109/08977194.2015.1077825 CrossRefPubMedGoogle Scholar

Copyright information

© Springer Nature B.V. 2018

Authors and Affiliations

  1. 1.Department of UrologyThe First Affiliated Hospital of Soochow UniversitySuzhouPeople’s Republic of China

Personalised recommendations